These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 35024784)

  • 21. Optogenetics for visual restoration: From proof of principle to translational challenges.
    Lindner M; Gilhooley MJ; Hughes S; Hankins MW
    Prog Retin Eye Res; 2022 Nov; 91():101089. PubMed ID: 35691861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of the Electronic Retinal Implant Alpha AMS in Restoring Vision to Blind Patients with End-Stage Retinitis Pigmentosa.
    Edwards TL; Cottriall CL; Xue K; Simunovic MP; Ramsden JD; Zrenner E; MacLaren RE
    Ophthalmology; 2018 Mar; 125(3):432-443. PubMed ID: 29110946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of vision restoration therapy after optic neuritis (VISION study): study protocol for a randomized controlled trial.
    Schinzel J; Schwarzlose L; Dietze H; Bartusch K; Weiss S; Ohlraun S; Paul F; Dörr J
    Trials; 2012 Jun; 13():94. PubMed ID: 22742888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ultrasound stimulation for non-invasive visual prostheses.
    Badadhe JD; Roh H; Lee BC; Kim JH; Im M
    Front Cell Neurosci; 2022; 16():971148. PubMed ID: 35990889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Restoring Color Perception to the Blind: An Electrical Stimulation Strategy of Retina in Patients with End-stage Retinitis Pigmentosa.
    Yue L; Castillo J; Gonzalez AC; Neitz J; Humayun MS
    Ophthalmology; 2021 Mar; 128(3):453-462. PubMed ID: 32858064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retinal optogenetic therapies: clinical criteria for candidacy.
    Jacobson SG; Sumaroka A; Luo X; Cideciyan AV
    Clin Genet; 2013 Aug; 84(2):175-82. PubMed ID: 23590195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The potential of the second sight system bionic eye implant for partial sight restoration.
    Luo YH; Fukushige E; Da Cruz L
    Expert Rev Med Devices; 2016 Jul; 13(7):673-81. PubMed ID: 27247995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Timing is Everything: Stochastic Optogenetic Stimulation Reduces Adaptation in Retinal Ganglion Cells.
    Kwan WC; Brunton EK; Begeng JM; Richardson RT; Ibbotson MR; Tong W
    Annu Int Conf IEEE Eng Med Biol Soc; 2023 Jul; 2023():1-4. PubMed ID: 38083106
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Visual rehabilitation of patients with advanced stages of glaucoma, optic atrophy, myopia or retinitis pigmentosa.
    Nilsson UL
    Doc Ophthalmol; 1988 Dec; 70(4):363-83. PubMed ID: 3266961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vision restoration training for glaucoma: a randomized clinical trial.
    Sabel BA; Gudlin J
    JAMA Ophthalmol; 2014 Apr; 132(4):381-9. PubMed ID: 24504128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-function correlations in Retinitis Pigmentosa patients with partially preserved vision: a voxel-based morphometry study.
    Rita Machado A; Carvalho Pereira A; Ferreira F; Ferreira S; Quendera B; Silva E; Castelo-Branco M
    Sci Rep; 2017 Sep; 7(1):11411. PubMed ID: 28900214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dampening Spontaneous Activity Improves the Light Sensitivity and Spatial Acuity of Optogenetic Retinal Prosthetic Responses.
    Barrett JM; Hilgen G; Sernagor E
    Sci Rep; 2016 Sep; 6():33565. PubMed ID: 27650332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved CoChR Variants Restore Visual Acuity and Contrast Sensitivity in a Mouse Model of Blindness under Ambient Light Conditions.
    Ganjawala TH; Lu Q; Fenner MD; Abrams GW; Pan ZH
    Mol Ther; 2019 Jun; 27(6):1195-1205. PubMed ID: 31010741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optogenetic approaches to restoring visual function in retinitis pigmentosa.
    Busskamp V; Roska B
    Curr Opin Neurobiol; 2011 Dec; 21(6):942-6. PubMed ID: 21708457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Residual vision activation and the brain-eye-vascular triad: Dysregulation, plasticity and restoration in low vision and blindness - a review.
    Sabel BA; Flammer J; Merabet LB
    Restor Neurol Neurosci; 2018; 36(6):767-791. PubMed ID: 30412515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Holographic optogenetic stimulation of patterned neuronal activity for vision restoration.
    Reutsky-Gefen I; Golan L; Farah N; Schejter A; Tsur L; Brosh I; Shoham S
    Nat Commun; 2013; 4():1509. PubMed ID: 23443537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optogenetic approaches to therapy for inherited retinal degenerations.
    De Silva SR; Moore AT
    J Physiol; 2022 Nov; 600(21):4623-4632. PubMed ID: 35908243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opsins for vision restoration.
    Simon CJ; Sahel JA; Duebel J; Herlitze S; Dalkara D
    Biochem Biophys Res Commun; 2020 Jun; 527(2):325-330. PubMed ID: 31982136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vision function testing for a suprachoroidal retinal prosthesis: effects of image filtering.
    Barnes N; Scott AF; Lieby P; Petoe MA; McCarthy C; Stacey A; Ayton LN; Sinclair NC; Shivdasani MN; Lovell NH; McDermott HJ; Walker JG
    J Neural Eng; 2016 Jun; 13(3):036013. PubMed ID: 27108845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A light in the dark: state of the art and perspectives in optogenetics and optopharmacology for restoring vision.
    Chemi G; Brindisi M; Brogi S; Relitti N; Butini S; Gemma S; Campiani G
    Future Med Chem; 2019 Mar; 11(5):463-487. PubMed ID: 30907134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.